Numinus Advances Phase 1 Trial on Proprietary Psilocybin Product

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/14/2026

1. JPM
2. BAC
3. SPY
4. WFC
5. ERAS
6. IBM
7. SPRO
8. TREX
9. AAPL
10. ORCL

Go back to Numinus Advances Phase 1 Trial on Proprietary Psilocybin Product
(AMEX: LKYSD) Delayed: 0.33 --0 (-0%)
Previous Close $0.33    52 Week High $0.04 
Open $0.89    52 Week Low $0.04 
Day High $0.33    P/E N/A 
Day Low $0.33    EPS $0.00 
Volume 0       

(NYSE: NUMI) Delayed: 25.08 --0 (-0%)
Previous Close $25.08    52 Week High $ 
Open $25.08    52 Week Low $ 
Day High $25.08    P/E N/A 
Day Low $25.08    EPS $ 
Volume 5,539